Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,577 | 142,162 | 172,692 | 184,632 | 192,048 |
| Marketable Securities | 151,436 | 156,756 | 167,046 | 169,851 | 151,202 |
| Receivables | 215,655 | 92,249 | 97,770 | 143,447 | 119,183 |
| Inventories | 82,090 | 89,764 | 78,674 | 63,092 | 57,938 |
| Income taxes - deferred | 44,365 | 42,529 | 43,170 | 33,993 | 38,586 |
| Other current assets | 0 | 0 | 0 | 0 | 1,444 |
| TOTAL | $698,927 | $545,543 | $583,392 | $641,934 | $649,696 |
| Non-Current Assets | |||||
| PPE Net | 176,963 | 180,758 | 171,126 | 136,888 | 126,886 |
| Intangibles | 68,383 | 75,524 | 81,746 | 89,210 | 74,571 |
| Other Non-Current Assets | 64,500 | 62,145 | 64,941 | 90,359 | 52,145 |
| TOTAL | $309,846 | $318,427 | $317,813 | $316,457 | $253,602 |
| Total Assets | $1,008,773 | $863,970 | $901,205 | $958,391 | $903,298 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,587 | 41,340 | 28,331 | 23,636 | 18,568 |
| Accrued Expenses | 143,165 | 97,678 | 142,570 | 236,460 | 204,517 |
| TOTAL | $178,204 | $145,295 | $183,229 | $272,839 | $241,011 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,452 | 6,277 | 12,328 | 12,743 | 17,926 |
| Other Non-Current Liabilities | 25,038 | 21,210 | 21,242 | 20,780 | 19,768 |
| TOTAL | $32,112 | $27,572 | $36,334 | $36,107 | $35,957 |
| Total Liabilities | $210,316 | $172,867 | $219,563 | $308,946 | $276,968 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,477 | 68,460 | 68,309 | 67,283 | 67,008 |
| Common Shares | 687 | 685 | 679 | 675 | 673 |
| Retained earnings | 478,056 | 372,614 | 367,815 | 347,778 | 329,106 |
| Other shareholders' equity | 1,590 | 5,087 | 4,164 | 2,046 | 3,208 |
| TOTAL | $798,457 | $691,103 | $681,642 | $649,445 | $626,330 |
| Total Liabilities And Equity | $1,008,773 | $863,970 | $901,205 | $958,391 | $903,298 |